Submit Manuscript  

Article Details


Small Molecular Leads Differentially Active Against HER2 Positive and Triple Negative Breast Cancer Cell Lines

Author(s):

Adnan Badran, Atia-tul-Wahab, Sharmeen Fayyaz, Elias Baydoun and M. Iqbal Choudhary*   Pages 1 - 5 ( 5 )

Abstract:


Background: Breast cancer is the most prevalent cancer type in women globally. It is characterized by distinct subtypes depending on different gene expression pattern. Oncogene HER2 is expressed on the surface of cell, and is responsible for cell growth regulation. Increase in HER2 receptor protein due to gene amplification, results in aggressive growth, and high metastasis in cancer cells. Method: The current study evaluates and compares the anti-breast cancer effect of commercially available compounds against HER2 overexpressing BT-474, and estrogen and HER2 negative MDA-MB-231 breast cancer cell lines. Results: Preliminary in vitro cell viability assays on these cell lines identified 6 lead molecules active against breast cancer. Convallatoxin, a steroidal lactone glycoside, showed the most potent activity with IC50 values of 0.63 ± 0.56, and 0.69 ± 0.08 μM against BT-474 and MDA-MB-231, respectively, whereas compounds 3 a phenol derivative, and compound 5 an indole alkaloid selectively inhibited the growth of BT-474, and MDA-MB-231 breast cancer cells, respectively. Conclusion: These results exhibited the potential of small molecules in the treatment of HER2 amplified and triple negative breast cancer in vitro.

Keywords:

Anti-cancer, Breast cancer, Human epidermal growth factor receptor-2 (HER2), Estrogen receptors, Heterocyclic compounds, Convallatoxin.

Affiliation:

Faculty of Pharmacy and Medicinal Sciences, University of Petra, Amman 1194, Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi-75270, H. E. J. Research Institute of Chemistry, 4International Center for Chemical and Biological Sciences, University of Karachi, Karachi-75270, Department of Biology, American University of Beirut, Beirut 1107 2020, Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi-75270



Read Full-Text article